fulvestrant has been researched along with Carcinoma, Papillary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandi, ML; Cavalli, L; Cavalli, T; Colli, E; Galli, G; Gozzini, A; Marini, F; Martineti, V; Nesi, G; Paglierani, M; Sorace, S; Tanini, A; Tognarini, I; Tonelli, F; Zonefrati, R | 1 |
| Chen, G; Tse, G; van Hasselt, C; Vlantis, A; Zeng, Q | 1 |
2 other study(ies) available for fulvestrant and Carcinoma, Papillary
| Article | Year |
|---|---|
In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Pancreatic Neoplasms; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |
The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
Topics: Apoptosis Inducing Factor; bcl-2-Associated X Protein; Carcinoma; Carcinoma, Papillary; Cell Death; Cell Proliferation; Cytochromes c; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; Humans; Neoplasm Proteins; Receptors, Estrogen; Subcellular Fractions; Thyroid Neoplasms; Tumor Cells, Cultured | 2008 |